J&J | JNJ - Чистый доход





Чистый доход Изменить Дата
AbbVie USD 695M 1.12B 2026-03
Abbott USD 1.08B 699M 2026-03
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Baxter International USD -15M 1.11B 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Biogen USD 319.5M 368.4M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
CONMED USD 13.83M 2.91M 2026-03
Cooper Companies USD -77.9M 208.7M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
J&J USD 5.24B 119M 2026-03
Medtronic USD 1.24B 100M 2026-03
Merck USD -4.24B 7.2B 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03
Zoetis USD 601M 2M 2026-03